Salute e Benessere
Companion Diagnostics Market Worth USD 15.6 Bn by 2030 Growing at 12.4% CAGR, says Mordor Intelligence
continues to dominate the companion diagnostics market, supported by a robust pharmaceutical pipeline, favorable reimbursement policies, and early adoption of molecular testing technologies. The region's regulatory clarity from the FDA for co-development of drugs and diagnostics has also streamlined commercialization pathways.
is emerging as the fastest-growing region, driven by an increasing cancer burden, expansion of genetic testing services, and the rapid development of localized diagnostic solutions in China , Japan , and India . National initiatives to integrate precision medicine into healthcare systems are further strengthening regional demand.
The growing emphasis on personalized medicine is reshaping treatment paradigms. Pharmaceutical companies increasingly rely on companion diagnostics to identify patient subgroups based on genetic or molecular profiles. This trend is particularly evident in oncology, where companion diagnostics guide the use of targeted therapies such as EGFR, HER2, and PD-L1 inhibitors.
The use of NGS-based testing platforms is transforming how we discover biomarkers and perform multiplex testing. By enabling comprehensive genomic profiling across multiple mutations, NGS helps reduce both turnaround time and cost per sample. This technology is also moving beyond oncology, finding new applications in infectious diseases, neurology, and cardiovascular research.
Pharmaceutical and diagnostic firms are increasingly forming strategic alliances to co-develop companion diagnostics alongside drug pipelines. These collaborations help align regulatory submissions and accelerate market entry timelines. Additionally, the integration of AI and bioinformatics tools is improving the interpretation of complex genomic data, supporting faster clinical decision-making.
https://www.mordorintelligence.com/industry-reports/companion-diagnostics-market?utm_source=prnewswire
The companion diagnostics market is moderately consolidated, with global diagnostics manufacturers, biotechnology companies, and technology providers actively advancing co-development partnerships and multiplex testing solutions. Market leaders focus on expanding companion tests across multiple cancer indications and investing in regulatory-approved NGS panels.
: The Oncology Molecular Diagnostics Market Report is Segmented by Product Type (Instrument), Technology (Polymerase Chain Reaction), Cancer Type (Breast Cancer), Sample Type (Tissue Biopsy, and More), End User (Hospitals), and Geography ( North America , Europe , Asia-Pacific , Middle East & Africa , South America ).
Illumina, QIAGEN, Roche, Thermo Fisher Scientific and Danaher are the major companies operating in this market.
: The Companion Animal Diagnostics Market report segments the industry into By Animals (Cats, Dogs, Other Animals), By Application (Bacteriology, Parasitology, Clinical Pathology, Other Applications), By Technology (Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, Other Diagnostics), and Geography ( North America , Europe , Asia-Pacific , Middle East and Africa , South America ).
Heska, Neogen, Zoetis, IDEXX and Innovative Diagnostics are the major companies operating in this market.
: The Anatomic Pathology Market Report is Segmented by Product & Services (Instruments, Consumables, and Services), Application (Disease Diagnosis, Drug Discovery & Development, and Other Applications), End User (Hospitals, Diagnostic Laboratories), Geography ( North America , Europe , Asia-Pacific , The Middle East and Africa , and South America ).
Thermo Fisher Scientific, Quest Diagnostics, Roche, LabCorp and Agilent Technologies are the major companies operating in this market.
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
media@mordorintelligence.com
https://www.mordorintelligence.com/contact-us
Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/companion-diagnostics-market-worth-usd-15-6-bn-by-2030-growing-at-12-4-cagr-says-mordor-intelligence-302605401.html